SURBER, MARK W.,BOSTIAN, KEITH A.,LOMOVSKAYA, OLGA,GRIFFITH, DAVID C.,DUDLEY, MICHAEL N.
申请号：
CA2608273
公开号：
CA2608273C
申请日:
2006.05.18
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
Disclosed herein are formulations of fluoroquinolones suitable foraerosolization and use of such formulations for aerosol administration offluoroquinolone antimicrobials for the treatment of pulmonary bacterialinfections. In particular, inhaled levofloxacin specifically formulated anddelivered for bacterial infections of the lungs is described. Methods includeinhalation protocols and manufacturing procedures for production and use ofthe compositions described.
